Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo

Low rates of cellular proliferation are associated with low GSH content and enhanced sensitivity of Ehrlich ascites-tumour (EAT) cells to the cytotoxic effects of recombinant human tumour necrosis factor (rhTNF-alpha). Buthionine sulphoximine, a selective inhibitor of GSH synthesis, inhibited tumour growth and increased rhTNF-alpha cytoxicity in vitro. Administration of sublethal doses (10(6) units/kg per day) of rhTNF-alpha, to EAT-bearing mice promoted oxidative stress (as measured by increases in intracellular peroxide levels, 0(2)(-.) generation and mitochondrial GSSG) and resulted in a slight reduction (19 %) in tumour cell number when controls showed the highest rate of cellular proliferation. ATP (1 mmol/kg per day)-induced selective GSH depletion, when combined with rhTNF-alpha administration, afforded a 61 % inhibition of tumour growth and resulted in a significant extension of host survival. Administration of N-acetylcysteine (1 mmol/kg per day) or GSH ester (5 mmol/kg per day) abolished the rhTNF-alpha and ATP-induced effects on tumour growth by maintaining high GSH levels in the cancer cells. Our results demonstrate that the sensitivity of tumour cells to rhTNF-alpha in vivo depends on their GSH content and their rate of proliferation.